Hyperglycemia is strongly correlated with
|
|
- Elijah Dalton
- 5 years ago
- Views:
Transcription
1 LITERATURE REVIEW Perioperative Hyperglycemia: A Literature Review Tammy S. Peacock, MAPSY, BSN, RN, NEA-BC, CENP, CPPS, CLSSBB ABSTRACT The purpose of this literature review is to examine current evidence and determine the effects of stress hyperglycemia on patient outcomes during the perioperative period. This review summarizes the pathophysiology of stress hyperglycemia, the population it affects, and strategies for optimal treatment to reduce the potential for postoperative complications. A literature search produced 16 of the most current studies on the effect of stress hyperglycemia in both the diabetic and nondiabetic populations. The evidence presented indicates the need to maintain tight glucose control in the perioperative patient. Although there are varying approaches to managing stress hyperglycemia, there is compelling agreement that stress hyperglycemia should be treated in all surgical patients. Key words: stress hyperglycemia, glucose control, surgical site infection, insulin resistance. Hyperglycemia is strongly correlated with increased mortality and morbidity in patients undergoing surgery In addition, undiagnosed insulin resistance is progressively more common on the day of surgery. 13 Perioperative hyperglycemia is a normal response to surgery and affects diabetic patients more than nondiabetic patients. 2 Perioperative- induced stress hyperglycemia has been linked to several postoperative complications, including sepsis, myocardial infarction, surgical site infection (SSI), and death. 2 Perioperative stress hyperglycemia can occur in patients admitted for various types of surgical procedures, including general, cardiac, vascular, and orthopedic surgery. 2 Insulin administration may attenuate some of the perioperative risks of hyperglycemia; however, target perioperative blood glucose levels remain controversial. 14 Tight perioperative glucose control with insulin may cause hypoglycemic events, which also are related to poor clinical outcomes and mortality. 9 Although hypoglycemia can be treated, it is sometimes a complicated condition because the signs are difficult to notice under anesthesia. 15 Current studies address intraoperative and postoperative periods, but limited research has been done to address preoperative glucose management or the glucose management of outpatient surgical patients. PURPOSE This literature review critically appraises and synthesizes the evidence regarding the effects of stress hyperglycemia in the perioperative period, reviews hyperglycemic treatment modalities, and correlates hyperglycemia with surgical complications using the most recent randomized control studies from the past five years. The research question was as follows: What are the recommended treatment options for perioperative stress hyperglycemia in inpatients and outpatients? RESEARCH METHODS I used key words to guide the search on October 20, 2017, for each of the following databases: Cumulative Index to Nursing and Allied Health Literature (CINAHL), PubMed, and Scopus. I entered subject subheadings and word truncations according to the individual database requirements and limited the search to literature published in English 80 AORN Journal AORN, Inc, 2019
2 January 2019, Vol. 109, No. 1 Perioperative Hyperglycemia from September 2011 through September The following individual search terms were used and included: stress hyperglycemia, glucose control, surgery, perioperative, surgical complications, tight glucose control, preoperative, inpatient, outpatient, morbidity, and mortality. For this review, I limited eligible studies to those that compared any type of glucose control in adult surgical patients with surgical complications. I excluded animal studies, laboratory-only studies, editorials, and conference presentations. The original search yielded 279 full-text articles. I removed duplicates, compared the remaining articles against the exclusion criteria, and removed additional studies that did not meet the inclusion criteria (Figure 1). The remaining 16 studies were included in this review. I evaluated and appraised these studies according to the strength and quality of the evidence using the AORN Research and Non- Research Evidence Appraisal Tools, 16 and assigned an appraisal score for each article (Supplementary Table 1). PATHOPHYSIOLOGY OF STRESS HYPERGLYCEMIA The causes of hyperglycemia in the perioperative period are multifactorial. An increase in sympathetic stimulation in addition to a rise in cortisol, glucagon, catecholamines, and growth hormone occurs during physiologic stress, causing disproportionate release of inflammatory cytokines. 17 Cortisol stimulates protein catabolism and hepatic glucose production. This increase in counter- regulatory hormones (ie, glucagon, growth hormones, cortisol) initiates a proliferation in endogenous glucose production via gluconeogenesis (Figure 2). 3 During the perioperative period, impaired insulin signaling and transient insulin resistance are believed to contribute to hyperglycemia in patients with and without diabetes mellitus. 3 This period of impaired insulin signaling and transient insulin resistance is believed to occur because of counter- regulatory hormone production and an excess of circulating proinflammatory cytokines. 3 The literature indicates that transient hyperglycemia is the body s response to decreased circulating insulin levels and is most prominent on the first day after an operation; however, it may continue for days. 3 Surgeries involving the abdomen and thorax have been correlated with a more prolonged and pronounced degree of hyperglycemia. Furthermore, less invasive (eg, laparoscopic) procedures have been related to less increase in insulin resistance. 3 Preoperative carbohydrate loading as advocated by the Enhanced Recovery After Surgery program may counteract the state of insulin resistance in surgical patients. 14 The use of carbohydrate- rich drinks avoids the catabolic rate associated with starvation. Carbohydrate loading also has been shown to increase insulin sensitivity, which decreases the risk of postoperative hyperglycemia. 18 A neuroendocrine stress response, which releases counterregulatory hormones, is a result of anesthesia and the surgical procedure. The scale of this counter- regulatory response is weighted by the type of anesthesia and the severity of the surgical procedure. 19 FINDINGS The studies in this review pertained to treating perioperative hyperglycemia, assessing the appropriate target level of blood glucose, and monitoring patient outcomes of hyperglycemia induced by surgical stress. Some of the studies were performed in patients with diabetes and some in patients without diabetes, and some studied both populations simultaneously. Figure 1. Flow chart showing the different phases of the systematic review. In 2008, Umpierrez et al 4 initiated a randomized controlled trial (RCT) that compared the efficacy of types of perioperative hyperglycemic control and documented the outcomes of study participants. Participants were excluded if AORN Journal 81
3 Peacock January 2019, Vol. 109, No. 1 Figure 2. Chart detailing the hormonal response to surgical stress. they were pregnant, had liver disease, had impaired renal function, underwent cardiac surgery, had a history of diabetic ketoacidosis, or had any mental condition that made them unable to consent. The group was randomized into two different groups. The researchers compared the inpatient management of general surgery patients with type 2 diabetes who were treated with basal- bolus glargine once daily and glulisine before meals if they were able to eat with a similar group of patients who were treated with sliding scale insulin four times a day. The results revealed that basal- bolus glargine showed significantly better glycemic control in patients with type 2 diabetes. The trial also showed a lower frequency of postoperative complications (eg, systemic or localized infections, organ failure) for this group. 4 In 2015, Umpierrez et al 5 conducted an RCT to determine the optimal goal for glycemic control in patients undergoing coronary artery bypass graft surgery. The researchers randomized a pool of 302 patients into two equal- sized groups: an intensive control group with a glucose target of 100 mg/deciliter (dl) to 140 mg/dl and a conservative control group with a glucose target of 141 mg/dl to 180 mg/dl. Findings from the study showed little significant difference in the rate of complications among the two groups of the diabetic population (49% for the intensive, 48% for conservative, P =.87). The study indicated that complications among patients without diabetes were significantly lower in the intensive control group using a target glucose level of between 100 mg/dl and 140 mg/dl compared with the conservative control group using a target glucose level of between 141 mg/dl and 180 mg/dl (34% and 55% respectively, P =.008). 5 Bláha et al 6 also looked specifically at tight glucose control (TGC) in nondiabetic patients aged 18 to 90 years who underwent major cardiac surgery between 2007 and There were two study groups: the perioperative group (n = 1134) and postoperative group (n = 1249). There also were two target ranges for blood glucose control: TGC (blood glucose of 4.4 millimoles [mmol]/l to 6.1 mmol/l) and glucose control (blood glucose of 4.4 mmol/l to 8.3 mmol/l). 6 The perioperative group showed a marked decrease (23.2%) in postoperative morbidity compared with the postoperative study group (34.1%; relative risk, 0.68; 95% CI, 0.60 to 0.78). The reduction in postoperative morbidity connected with the intraoperative initiation of TGC was predominately driven by nondiabetic patients. 6 Akbarzadeh et al 7 conducted an RCT that investigated the effect of a new metabolic conditioning supplement on nondiabetic coronary artery bypass patient 82 AORN Journal
4 January 2019, Vol. 109, No. 1 Perioperative Hyperglycemia outcomes. The supplement was composed of L- carnitine (3 g), vitamin C (750 mg), glutamine (15 g), selenium (150 μg), and vitamin E (250 mg), and was designed exclusively for this study. For this RCT, 89 nondiabetic patients with an ejection fraction greater than 30% and who were scheduled for coronary artery bypass grafting were divided into four groups. Groups received either the supplement, a placebo, or a combination of supplement and placebo before and after surgery. 7 The groups were assigned as follows: 1. supplement before surgery and placebo after surgery (n = 27), 2. placebo before surgery and supplement after surgery (n = 26), 3. supplement both before and after surgery (n = 26), and 4. placebo both before and after surgery (n = 26). These researchers found that when they compared the results of the groups, all showed an increase in glucose postoperatively; however, the placebo group showed the highest increase. The patients who used the supplement both before and after maintained better controlled blood glucose levels during the perioperative period (P =.004). 7 Treatment Recommendations There are many different recommendations about glucose control in the literature, and some of the recommendations vary regarding the appropriate level of glucose control. The University of Washington Medical Center used a very tight glycemic control protocol that began with an insulin infusion with a glucose concentration of greater than 140 mg/dl to maintain a target glucose level of 100 mg/dl to 140 mg/dl. The protocol used four separate algorithms: one for type 1 diabetic patients, one for type 2 diabetic patients, and two for patients in which the target glucose level did not decrease by a prescribed amount. Intraoperative glucose was measured by a point- of- care test completed by anesthesia providers. 8,21 There are many different recommendations about glucose control in the literature, and some of the recommendations vary regarding the appropriate level of glucose control. Patient Outcomes of Stress- Induced Hyperglycemia Richards et al 11 studied the relationship between stressinduced hyperglycemia and postoperative infections of 187 trauma patients who sustained orthopedic injuries. The patient population they studied did not have a history of diabetes and the target blood glucose level for these intensive care unit patients was between 80 mg/dl and 110 mg/dl. Results of this study indicated that the risk for an SSI was increased in patients with hyperglycemia being treated for orthopedic injuries (P =.047). 11 Kiran et al 20 studied the effect of hyperglycemia in a nondiabetic colorectal surgery patient population. This study was retrospective and included 16,404 postoperative glucose measurements in 2,447 patients. Of this group, 66% showed elevated glucose levels above 125 mg/dl. This study showed septic complications and mortality were associated with hyperglycemia. Hyperglycemia also was associated with both infectious and noninfectious complications, with correlation increasing for patients with an increasing American Society of Anesthesiologists class and the severity of blood loss. 20 A study by Takesue and Tsuchida 9 at the Hyogo College of Medicine divided a patient population into surgical patients and critically ill surgical patients. The goal for the surgical patients was to maintain a glucose level of 110 mg/dl to 150 mg/dl, and for critically ill patients, the goal was a glucose level of 140 mg/dl to 180 mg/dl. This study resulted in a recommendation for both groups of patients to start an insulin infusion when the patient s glucose reached >150 mg/dl. 9 Evans et al 10 reviewed studies completed between 2001 and 2008 and differentiated between noncritically ill and critically ill surgical patients. Based on the information from the studies, these researchers recommended the use of subcutaneous insulin bolus therapy with a sliding scale to maintain blood glucose between 140 mg/dl and 180 mg/dl in the noncritically ill surgical patients when the fasting blood glucose was greater than 140 mg/dl or random blood glucose was greater than 180 mg/dl. The researchers recommended that the insulin infusion for critically ill patients should be started with a blood glucose level greater than 180 mg/dl with the goal of a blood glucose of 140 mg/dl to 180 mg/dl. 10 Researchers investigated another treatment option for perioperative AORN Journal 83
5 Peacock January 2019, Vol. 109, No. 1 Key Takeaways Stress hyperglycemia not only affects postoperative morbidity and mortality in diabetic perioperative patients, but also in nondiabetic perioperative patients. Tight glucose control during the perioperative period is supported by available evidence. Perioperative hyperglycemia may be treated with either subcutaneous insulin or an IV insulin infusion. Additional research is needed to develop hyperglycemia treatment recommendations for both inpatients and outpatients. hyperglycemia in which they did not divide the patients, but treated patients with a blood glucose of 140 mg/dl to 180 mg/dl with subcutaneous insulin and then initiated insulin infusion for those with a blood glucose greater than 180 mg/dl. 5 DISCUSSION The evidence presented in these studies shows a clear relationship between the level of glycemic control and complications after surgery. Most studies were based on cardiac, complex general, and orthopedic surgeries. In the orthopedic study, musculoskeletal trauma suggests a greater effect on hyperglycemia and increased rate of SSIs. 11 The studies that investigated outcomes of hyperglycemia concluded that nondiabetic patients were at greater risk for poorer outcomes than diabetic patients. Even with evidence to provide glucose control, compliance among anesthesia professionals is poor, possibly because of fear of a hypoglycemic effect. 8,21 Many of the studies supported the need for perioperative glucose monitoring, 1,2,5,6,8,10,14,20,21 and additional studies showed a correlation between random elevated blood glucose readings and postoperative complications. 12,20 Perioperative nurses and leaders continue to struggle with the question of how to encourage compliance with blood glucose monitoring and initiation of treatment when the evidence shows that the risk of adverse outcomes is significant for both diabetic and nondiabetic populations. Additional research is needed to reach a consensus on standardizing treatment practice for perioperative hyperglycemia. Standardized treatment recommendations may provide better guidance for providers to comply with protocols to treat hyperglycemia. Currently there are operational challenges with using IV insulin. More surgeries are being moved to outpatient facilities, which may not have the resources to assess and treat hyperglycemia. The existing protocols are directed toward inpatient facilities and have great variation on the best methodology of glucose control. As the number of inpatient surgeries moving to the outpatient arena increases, the need for facility leaders to develop outpatient perioperative hyperglycemic management protocols to decrease the risk of postoperative complications also increases. There is a need for more hyperglycemic research in the outpatient environment. Akbarzadeh et al 7 discussed the effect that glutamine and arginine can have on controlling insulin resistance by metabolic regulation and postoperatively by decreased cell injury, increased peripheral glucose utilization, and increased antioxidant capacity. A newly recognized L- carnitine, which is used as an adjunct therapy for type 2 diabetes, showed efficacy in controlling insulin resistance by means of increased fatty acid oxidation. 7 This therapy might have a positive effect on the treatment of outpatient surgical patients because it may provide adequate glycemic control without interfering with the operational needs of the perioperative space. LIMITATIONS This literature review had some limitations, including a small sample size, single institution used, first study for a newly developed medication, limitations on surgery type, and a single researcher reviewing and scoring articles. Another limitation of this review was the exclusion of non English language literature because of the lack of interpretation services. In addition, one study that was conducted more than five years ago was included in this review because it is considered an important reference to perioperative hyperglycemia. 84 AORN Journal
6 January 2019, Vol. 109, No. 1 Perioperative Hyperglycemia CONCLUSION Perioperative hyperglycemia has a significant correlation with adverse surgical outcomes, and blood glucose should be monitored in both the diabetic and nondiabetic surgical patient populations. The literature shows a need for a standard treatment protocol for perioperative hyperglycemia in all surgical patients regardless of surgical specialty. Whether critically ill patients should have different treatment standards than the general population is unknown. Standards for the treatment of hyperglycemia could increase compliance with treatment protocols and lessen the fear of hypoglycemia. The literature lacked any recommendations for outpatient surgical patients, which is a concern because of the increase in surgical procedures being performed in outpatient settings. The risk for perioperative hyperglycemia exists in all patients and should be monitored and treated to prevent adverse surgical complications. Editor s notes: CINAHL, Cumulative Index to Nursing and Allied Health Literature, is a registered trademark of EBSCO Industries, Birmingham, AL. PubMed is a registered trademark of the US National Library of Medicine, Bethesda, MD. SCOPUS is a registered trademark of Elsevier BV, Amsterdam, the Netherlands. SUPPORTING INFORMATION Additional information may be found online in the supporting information tab for this article. REFERENCES 1. Kwon S, Thompson R, Dellinger P, Yanez D, Farrohki E, Flum D. Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program. Ann Surg. 2013;257(1): Mohan S, Kaoutzanis C, Welch KB, et al. Postoperative hyperglycemia and adverse outcomes in patients undergoing colorectal surgery: results from the Michigan surgical quality collaborative database. Int J Colorectal Dis. 2015;30(11): Palermo NE, Gianchandani RY, McDonnell ME, Alexanian SM. Stress hyperglycemia during surgery and anesthesia: pathogenesis and clinical implications. Curr Diab Rep. 2016;16(3): Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal- bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34(2): Umpierrez G, Cardona S, Pasquel F, et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO- CABG trial. Diabetes Care. 2015;38(9): Bláha J, Mráz M, Kopecký P, et al. Perioperative tight glucose control reduces postoperative adverse events in nondiabetic cardiac surgery patients. J Clin Endocrinol Metab. 2015;100(8): Akbarzadeh M, Eftekhari MH, Shafa M, Alipour S, Hassanzadeh J. Effects of a new metabolic conditioning supplement on perioperative metabolic stress and clinical outcomes: a randomized, placebocontrolled trial. Iran Red Crescent Med J. 2016;18(1): e Grunzweig K, Nair BG, Peterson GN, et al. Decisional practices and patterns of intraoperative glucose management in an academic medical center. J Clin Anesth. 2016;32: Takesue Y, Tschida T. Strict glycemic control to prevent surgical site infections in gastroenterological surgery. Ann Gastroenterol Surg. 2017;1: Evans CH, Lee J, Ruhlman MK. Optimal glucose management in the perioperative period. Surg Clin North Am. 2015;95(2): Richards JE, Kauffmann RM, Obremskey WT, May AK. Stress- induced hyperglycemia as a risk factor for surgical- site infection in nondiabetic orthopedic trauma patients admitted to the intensive care unit. J Orthop Trauma. 2013;27(1): Wang R, Panizales MT, Hudson MS, Rogers SO, Schnipper JL. Preoperative glucose as a screening tool in patients without diabetes. J Surg Res. 2014;186(1): Frisch A, Chandra P, Smiley D, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care. 2010;33(8): Duggan EW, Carlson K, Umpierrez GE. Perioperative hyperglycemia management: an update. Anesthesiology. 2017;126(3): AORN Journal 85
7 Peacock January 2019, Vol. 109, No Akhtar S, Barash PG, Inzucchi SE. Scientific principles and clinical implications of perioperative glucose regulation and control. Anesth Analg. 2010;110(2): Spruce L, Van Wicklin SA, Wood A. AORN s revised model for evidence appraisal and rating. AORN J. 2016;103(1): Barth E, Albuszies G, Baumgart K, et al. Glucose metabolism and catecholamines. Crit Care Med. 2007;35(9 suppl):s508 S Tamura T, Yatabe T, Kitagawa H, Yamashita K, Hanazaki K, Yokoyama M. Oral carbohydrate loading with 18% carbohydrate beverage alleviates insulin resistance. Asia Pac J Clin Nutr. 2013;22(1): Dobyns JB. General anaesthesia tutorial #327: perioperative insulin management. Anesthesia Tutorial of the Week. com_virtual_library/media/aa40c611099b3913bc ce8b2535-Perioperative-insulin-management. pdf. Published March 18, Accessed October 1, Kiran RP, Turina M, Hammel J, Fazio V. The clinical significance of an elevated postoperative glucose value in nondiabetic patients after colorectal surgery: evidence for the need for tight glucose control? Ann Surg. 2013;258(4): Nair BG, Grunzweig K, Peterson GN, et al. Intraoperative blood glucose management: impact of a real- time decision support system on adherence to institutional protocol. J Clin Monit Comput. 2016;30(3): Tammy S. Peacock, Master of Arts in Health Psychology (MAPSY), BSN, RN, Nursing Executive Advanced, Board Certified (NEA- BC), Certified Executive in Nursing Practice (CENP), Certified Professional in Patient Safety (CPPS), Certified Lean Six Sigma Black Belt (CLSSBB), is the surgical outcomes improvement leader at Kaiser Permanente in Oakland, CA. Ms Peacock has no declared affiliation that could be perceived as posing a potential conflict of interest in the publication of this article. 86 AORN Journal
Not Too Sweet in the OR Suite: Perioperative Glucose Management Update
Not Too Sweet in the OR Suite: Perioperative Glucose Management Update Legacy Emanuel Medical Center, Portland, Oregon Ron Barbosa, MD, NSQIP Surgeon Champion Becky Swick, BSN, NSQIP SCR (Retired) Presented
More information9/23/09. What are the key components of preoperative, intraoperative, & postoperative care of diabetes management? Rebecca L. Sturges, M.D.
RMHS Perioperative Summit: Perioperative Diabetes Management Rebecca L. Sturges, M.D. Oct 6, 2009 Mrs. B was referred by her orthopedic surgeon to your preoperative clinic to discuss medical management
More informationHAP PA-HEN Achieving More Together
HAP PA-HEN Achieving More Together Managing Hyperglycemia in the Hospital: Strategies for Safe and Effective Care Pennsylvania Patient Safety Authority Managing Hyperglycemia in the Hospital: Strategies
More informationBasal Bolus Insulin Therapy Frequently Asked Questions
1. What is Basal Bolus Insulin Therapy (BBIT)? 2. What evidence supports the use of subcutaneous Basal Bolus Insulin Therapy? 3. Does Basal Bolus Insulin Therapy apply to all patients? 4. What s wrong
More informationPreoperative Screening for Hyperglycemia Risk, Preoperative CHO, and Perioperative Glucose Control. E. Patchen Dellinger, MD
Preoperative Screening for Hyperglycemia Risk, Preoperative CHO, and Perioperative Glucose Control E. Patchen Dellinger, MD Disclosure Slide Dr. Dellinger has worked in the area of clinical trials with
More informationDeepika Reddy MD Department of Endocrinology
Deepika Reddy MD Department of Endocrinology Management of hyperglycemic crisis Review need for inpatient glycemic control Brief overview of relevant trials Case based review of diabetes management strategies/review
More informationParenteral Nutrition The Sweet and Sour Truth. From: Division of Endocrinology, Diabetes and Bone Disease Icahn School of Medicine at Mount Sinai
ENDOCRINE PRACTICE Rapid Electronic Article in Press Rapid Electronic Articles in Press are preprinted manuscripts that have been reviewed and accepted for publication, but have yet to be edited, typeset
More informationThe effect of insulin therapy algorithms on blood glucose levels in patients following cardiac surgery: A systematic review protocol
The effect of insulin therapy algorithms on blood glucose levels in patients following cardiac surgery: A systematic review protocol Megan Higgs, BN, MN, PhD Candidate 1,3 Ritin Fernandez, BSc (Nursing),
More informationVANDERBILT UNIVERSITY MEDICAL CENTER MULTIDISCIPLINARY SURGICAL CRITICAL CARE TRAUMA INTENSIVE CARE UNIT GLYCEMIC CONTROL PROTOCOL
VANDERBILT UNIVERSITY MEDICAL CENTER MULTIDISCIPLINARY SURGICAL CRITICAL CARE TRAUMA INTENSIVE CARE UNIT GLYCEMIC CONTROL PROTOCOL Background: For some time, the presence of diabetes and hyperglycemia
More informationShould Continuous Subcutaneous Insulin Infusion (CSII) Pumps Be Used During the Perioperative Period? Development of a Clinical Decision Algorithm
Should Continuous Subcutaneous Insulin Infusion (CSII) Pumps Be Used During the Perioperative Period? Development of a Clinical Decision Algorithm LCDR Shannan Rotruck, MSN, CRNA, NC, USN LCDR Lauren Suszan,
More informationSpecial Situations 1
Special Situations 1 Outline Continuous Nutrition Tube feeds TPN Steroids Pumps Perioperative BG Control 2 Patient receiving continuous TF or TPN Continuous nutrition coverage options: Analog q4hr Regular
More informationIn - Hospital Diabetes Care. A review and personal experience
In - Hospital Diabetes Care A review and personal experience Hyperglycemia in the Hospital The Problem Hospitalizations with Diabetes http://www.cdc.gov/diabetes/statistics/dmany/fig1.htm Prevalence of
More informationPerioperative Glycemic Control Implementation
Perioperative Glycemic Control Implementation in a Community Hospital Shaun Sullivan, MD & Janice Whitman,RN MSN CCRN Perioperative Medical Director & CNS Critical Care, APN Skagit Valley Hospital Bellingham
More informationWhat s so sweet about glycemic control? June 3, 2016
What s so sweet about glycemic control? June 3, 2016 Objectives Provide an overview of why glucose control is important in surgical patient outcomes. Demonstrate an understanding of how anesthetics and
More informationStress Response to Surgery Under General Anesthesia in Type 2 Diabetic Patient
Stress Response to Surgery Under General Anesthesia in Type 2 Diabetic Patient Dr Kawsar Sardar, MD Associate professor Department of Anesthesiology, BIRDEM, Bangladesh Joint secretary, Bangladesh Society
More informationTHE USE OF INSULIN TO REDUCE SURGICAL SITE INFECTIONS (SSIS) CAPTAIN DAVID BRADLEY MAJ JASMINE HOGAN MAJ KYONG WINKLER
THE USE OF INSULIN TO REDUCE SURGICAL SITE INFECTIONS (SSIS) CAPTAIN DAVID BRADLEY MAJ JASMINE HOGAN MAJ KYONG WINKLER OVERVIEW AND SIGNIFICANCE Surgical Sites infections is the 2nd most reported HAI in
More informationA Children s Bedtime Story
A Children s Bedtime Story Setting: University Medical Center, Big Town, USA Scenario: 0500, last admission of the night, 10 previous admissions, all tucked in for the night Patient: 75 year old male with
More informationApril Dear (Editor):
April 2014 Dear (Editor): Registered Dietitians (RD) play an integral role in patient care in the medical intensive care unit. RD s have increased knowledge in blood glucose control and reducing adverse
More informationEvidence for Basal Bolus Insulin Versus Slide Scale Insulin
Curr Emerg Hosp Med Rep (2014) 2:26 34 DOI 10.1007/s40138-013-0032-4 DIABETES AND METABOLIC DISEASE (W FORD, SECTION EDITOR) Evidence for Basal Bolus Insulin Versus Slide Scale Insulin Sameer Badlani William
More informationHow to manage type 2 diabetes in medical and surgical patients in the hospital
MEDICAL GRAND ROUNDS CME CREDIT EDUCATIONAL OBJECTIVE: Readers will learn the relationship between glycemic control and clinical outcomes in hospitalized medical and surgical patients who are not in an
More informationΑναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς
Αναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς Αναστασία Θανοπούλου Επίκουρη Καθηγήτρια Β Παθολογικής Κλινικής Πανεπιστημίου Αθηνών Διαβητολογικό Κέντρο, Ιπποκράτειο Νοσοκομείο
More informationMeeting the Challenge of Inpatient Glycemic Management in the Non-Critical Care Setting
Meeting the Challenge of Inpatient Glycemic Management in the Non-Critical Care Setting Jane Jeffrie Seley, DNP, MPH, GNP, BC-ADM, CDE, CDTC, FAAN, FAADE Diabetes Nurse Practitioner, Inpatient Diabetes
More informationInpatient Management of Hyperglycemia Guillermo Umpierrez, MD, CDE Saturday, February 10, :30 a.m. 11:15 a.m.
Inpatient Management of Hyperglycemia Guillermo Umpierrez, MD, CDE Saturday, February 10, 2018 10:30 a.m. 11:15 a.m. There are over 7.5 million hospital admissions for patients with diabetes in the US.
More informationTransition of Care in Hospitalized Patients with Hyperglycemia and Diabetes
Transition of Care in Hospitalized Patients with Hyperglycemia and Diabetes Critically ill patients in the ICU Hospital Non-ICU Settings Home Guillermo E Umpierrez, MD, FACP, FACE Professor of Medicine
More informationManagement of Inpatient Hyperglycemia: 2011 Endocrine Society Meeting Hyperglycemia in Critically ill patients in ICU Settings.
Management of Inpatient Hyperglycemia: 2011 Endocrine Society Meeting Guillermo E. Umpierrez, MD, Emory University School of Medicine and Jack Leahy, MD, University of Connecticut Hyperglycemia in Critically
More informationAPPENDIX American Diabetes Association. Published online at
APPENDIX 1 INPATIENT MANAGEMENT OF TYPE 2 DIABETES No algorithm applies to all patients with diabetes. These guidelines apply to patients with type 2 diabetes who are not on glucocorticoids, have no
More informationACUTE ABDOMEN IN DIABETIC PATIENTS ANALYSIS OF COMPLICATIONS AND MORTALITY
2014 ILEX PUBLISHING HOUSE, Bucharest, Roumania http://www.jrdiabet.ro Rom J Diabetes Nutr Metab Dis. 21(4):277-284 doi: 10.2478/rjdnmd-2014-0034 ACUTE ABDOMEN IN DIABETIC PATIENTS ANALYSIS OF COMPLICATIONS
More informationGLYCEMIC CONTROL SURVEY
GLYCEMIC CONTROL SURVEY Objective: To gain an understanding of the current state of glycemic control (ie, intensive insulin therapy and frequent blood glucose testing) protocol use in hospital inpatients.
More informationExecutive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)
Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) SETTING FOR STAFF PATIENTS Medical and nursing staff Children and young
More informationSection of Endocrinology, Rush University Medical Center, Chicago, Illinois.
ORIGINAL RESEARCH Treatment of Inpatient Hyperglycemia Beginning in the Emergency Department: A Randomized Trial Using Insulins Aspart and Detemir Compared With Usual Care Jennifer B. Bernard, MD Christina
More informationAccurate Timing of Insulin Administration.
Lehigh Valley Health Network LVHN Scholarly Works Patient Care Services / Nursing Accurate Timing of Insulin Administration. Elizabeth Ajamu BSN, RN Lehigh Valley Health Network, elizabeth_o.ajamu@lvhn.org
More informationDisclosures. Glycemic Control in the Intensive Care Unit. Objectives. Hyperglycemia. Hyperglycemia. History. No disclosures
Disclosures Glycemic Control in the Intensive Care Unit No disclosures Jorie Frasiolas, Pharm.D., BCPS Clinical Pharmacy Manager, CTICU NewYork-Presbyterian Hospital Columbia University Medical Center
More informationInpatient Management of Diabetes Mellitus. Jessica Garza, Pharm.D. PGY-1 Pharmacotherapy Resident TTUHSC School of Pharmacy
Inpatient Management of Diabetes Mellitus Jessica Garza, Pharm.D. PGY-1 Pharmacotherapy Resident TTUHSC School of Pharmacy 2 Disclosure Jessica Garza does not have any actual or potential conflicts of
More informationGlycemic Control Insulin In The Hospital Setting
Glycemic Control Insulin In The Hospital Setting Glycemic Control The Evidence For Insulin s s Benefit The Mechanism of Insulin s s Benefit The Achievement of Insulin s s Benefit A Few Cases Hyperglycemia
More informationInpatient Glycemic Management 2016
2016 Jim Chamberlain MD Medical Director for Diabetes Services St. Mark s Hospital and St. Mark s Diabetes Center Salt Lake City, Utah Disclosures Speakers Bureaus Merck & Co. Janssen Pharmaceutical Companies
More informationInpatient Management of Hyperglycemia Guillermo Umpierrez, MD, CDE Saturday, February 10, :30 a.m. 11:15 a.m.
Inpatient Management of Hyperglycemia Guillermo Umpierrez, MD, CDE Saturday, February 1, 218 1:3 a.m. 11:15 a.m. There are over 7.5 million hospital admissions for patients with diabetes in the US. About
More informationThe Art and Science of Infusion Nursing Gwen Klinkner, MS, RN, APRN, BC-ADM, CDE
The Art and Science of Infusion Nursing Gwen Klinkner, MS, RN, APRN, BC-ADM, CDE The Importance of Glycemic Control in the Hospital and the Role of the Infusion Nurse ABSTRACT Diabetes is reaching epidemic
More information123 Are You Providing Evidence-Based Diabetes Care? - Martin
Donna Martin, DNP, RN, CDE, CMSRN Lewis University Learner will be able to: Identify current inpatient standards of care for patients with diabetes Describe causes of hyperglycemia / hypoglycemia in the
More informationLearning Objectives. Perioperative SWEET Success
Perioperative SWEET Success PERIOPERATIVE SWEET SUCCESS PRESENTED BY: KENDRA MARTIN, RN, BSN, CDE JENNIFER SIMPSON, RN, BC-ADM, MSN, CNS Disclosure to Participants Notice of Requirements For Successful
More informationThe Many Faces of T2DM in Long-term Care Facilities
The Many Faces of T2DM in Long-term Care Facilities Question #1 Which of the following is a risk factor for increased hypoglycemia in older patients that may suggest the need to relax hyperglycemia treatment
More informationNOT-SO-SWEET! THE STRAIGHT SCOOP ON DIABETES IN THE HOSPITAL SETTING
Sharp HealthCare s 2016 Diabetes Conference November 11, 2016 NOT-SO-SWEET! THE STRAIGHT SCOOP ON DIABETES IN THE HOSPITAL SETTING Tamara Swigert, MSN, RN, CDE Speaker Disclosure Tammy Swigert has no conflicts
More informationprolonged hospital stay, infections, and disability after hospital discharge, and death (1 3). Several clinical trials in
Clinical Care/Education/Nutrition/Psychosocial Research O R I G I N A L A R T I C L E Randomized Study Comparing a Basal Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of
More information4/10/2015. Foundations to Managing Inpatient Hyperglycemia. Learning Objectives
Foundations to Managing Inpatient Hyperglycemia Module A 1 Learning Objectives Develop strategies to identify patients with hyperglycemia or diabetes in the inpatient setting Establish glycemic goals to
More informationInpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin
Inpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin David Newman, MD University of North Dakota School of Medicine Sanford Health Big Sky Conference 2017 Dr. David Newman, Personal/Professional
More informationEffective Health Care Program
Comparative Effectiveness Review Number 57 Effective Health Care Program Methods for Insulin Delivery and Glucose Monitoring: Comparative Effectiveness Executive Summary Background Diabetes mellitus is
More informationFundamentals of Exercise Physiology and T1D
COMPLIMENTARY CE Fundamentals of Exercise Physiology and T1D Jointly Provided by Developed in collaboration with 1 INTRODUCTION TO PHYSICAL ACTIVITY AND T1D 2 Many People with T1D Have Lower Levels of
More informationWelcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1
Welcome Everyone Sign-In Enjoy Breakfast Meet someone new Enter Raffle Pick a team name Please silence phones We start at 8:00am Monitoring, Sick Days, Inpatient Management - Objectives Objectives: Strategies
More informationDiabetic Ketoacidosis
October 2015 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Case History HPI: 24 yo man with recent 8 lb. weight loss, increased thirst and frequent
More informationC CONFERENCIAS MAGISTRALES Vol. 36. Supl. 1 Abril-Junio 2013 pp S61-S68 Management of hyperglycemia in the perioperative patient. 39 th Annual Refresher Course on Anesthesiology and Perioperative Medicine,
More informationLet s not sugar coat it: Promoting excellence in glucose control in hospitalized and perioperative patients WELCOME!
Let s not sugar coat it: Promoting excellence in glucose control in hospitalized and perioperative patients WELCOME! 1. Evaluate the evidence for variable glycemic control for patients in the hospital
More informationControl of Blood Glucose in the ICU: Reconciling the Conflicting Data
Control of Blood Glucose in the ICU: Reconciling the Conflicting Data Steven E. Nissen MD Disclosure Consulting: Many pharmaceutical companies Clinical Trials: AbbVie, Amgen, Astra Zeneca, Esperion, Eli
More informationReceived: 23 September Accepted: 17 October 2009
ORIGINAL ARTICLE Comparing Effects of Continuous Insulin Infusion with or without Subcutaneous Glargine Insulin on Glycemic Control in Diabetic Patients Undergoing Coronary Artery Bypass Graft (CABG) Seyed
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adolescents, increase in type 2 diabetes in, 480 Albuminuria, and neuropathy, exercise in, 435 Arterial disease, peripheral, tests for, to assess
More informationESPEN Congress Madrid 2018
ESPEN Congress Madrid 2018 Dysglycaemia In Acute Patients With Nutritional Therapy Mechanisms And Consequences Of Dysglycaemia In Patients Receiving Nutritional Therapy M. León- Sanz (ES) Mechanisms and
More informationInitial Management of Septic Patients with Hyperglycemia in the Noncritical Care Inpatient Setting
CLINICAL RESEARCH STUDY Initial Management of Septic Patients with Hyperglycemia in the Noncritical Care Inpatient Setting Philipp Schuetz, MD, a Maura Kennedy, MD, a Jason M. Lucas, MD, MPH, a Michael
More informationPerioperative Management of the Patient with Endocrine Disease: A Focus on Diabetes & Thyroid Dysfunction
Perioperative Management of the Patient with Endocrine Disease: A Focus on Diabetes & Thyroid Dysfunction Luigi Meneghini, MD, MBA Professor, Internal Medicine (Endocrinology), UT Southwestern Medical
More information5/15/2018 DISCLOSURE OBJECTIVES. FLORIDA HOSPITAL ORLANDO Not for profit organization Acute care medical center 1,368 licensed beds BACKGROUND
DISCLOSURE PHARMACIST DIRECTED MANAGEMENT OF GLUCOCORTICOID INDUCED HYPERGLYCEMIA AT A LARGE COMMUNITY HOSPITAL Jill Zaccardelli, PharmD PGY1 Pharmacy Resident Florida Hospital Orlando Jill.Zaccardelli@flhosp.org
More informationNon-insulin treatment in Type 1 DM Sang Yong Kim
Non-insulin treatment in Type 1 DM Sang Yong Kim Chosun University Hospital Conflict of interest disclosure None Committee of Scientific Affairs Committee of Scientific Affairs Insulin therapy is the mainstay
More informationMeasure Information Form
Release Notes: Measure Information Form Version 2.5 **NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE** Measure Information Form Measure Set: Surgical Care Improvement Project (SCIP) Set Measure
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE TREATMENT OF HYPERGLYCEMIA - ADULT SCOPE Provincial: Acute Care APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Diabetes, Obesity & Nutrition Strategic Clinical Network PARENT
More informationCAN TAKE TRIAL C ONTINUA TION OF MET FORMIN TO IMPROVE A ND KEEP PERI- OPERATIVE GLYCEMIC CONTROL DR. JOSEPH FIORELLINO DR.
CAN TAKE TRIAL C ONTINUA TION OF MET FORMIN TO IMPROVE A ND KEEP PERI- OPERATIVE GLYCEMIC CONTROL DR. JOSEPH FIORELLINO DR. JAMES PAUL Rational for Study There are currently 60 million Europeans and 2
More informationUNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY
1 UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GLUCOSE HOMEOSTASIS An Overview WHAT IS HOMEOSTASIS? Homeostasis
More informationQI Successes & Failures Learning from Both
QI Successes & Failures Learning from Both E. Patchen Dellinger, MD, FACS, FIDSA, FSHEA Professor of Surgery University of Washington Medical Center (UWMC), Seattle, Washington Conflict of Interest Over
More informationNova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)
Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines) Authors: Dr. M. Love, Kathy Harrigan Reviewers:
More informationSociety for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery
Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Girish P. Joshi, MB BS, MD, FFARCSI Anesthesia & Analgesia
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE GLYCEMIC MANAGEMENT - ADULT SCOPE Provincial: Acute Care APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Diabetes, Obesity & Nutrition Strategic Clinical Network PARENT DOCUMENT
More informationIn-Hospital Management of Diabetes
In-Hospital Management of Diabetes Clinical order sets guidelines.diabetes.ca diabetes.ca 1-800-BANTING (226-8464) Table of Contents Key elements from the Canadian Diabetes Association 2013 Clinical Practice
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Effect of Surgery on Post Operative Blood Sugar Level among Non Diabetic Patients with N P
More informationHBA1C AS A MARKER FOR HIGH RISK DIABETIC SURGICAL PATIENT
Basrah Journal Of Surgery Bas J Surg, September, 18, 2012 HBA1C AS A MARKER FOR HIGH RISK DIABETIC SURGICAL PATIENT MB,ChB, DA, FICMS, Lecturer in Anesthesiology, Department of Surgery, College of Medicine,
More informationHyperglycemia Procedure: Management and Treatment Adult Patients
Approved by: Chief Operating Officer; and Chief Medical Officer Hyperglycemia Procedure: Management and Treatment Corporate Policy & Procedures Manual Number: VII-B-465 Date Approved January 23, 2018 Date
More informationMartin J Stevens MD, FRCP, Endocrinologist and Professor of Medicine
The Approach to Inpatient Hyperglycemia Martin J Stevens MD, FRCP, Endocrinologist and Professor of Medicine Great Lakes Hospital Medical Symposium May 7th 2010 Further Increases in the Prevalence of Diabetes
More informationIn-Hospital Management of Diabetes. Dr Benjamin Schiff Assistant Professor McGill University
In-Hospital Management of Diabetes Dr Benjamin Schiff Assistant Professor McGill University No conflict of interest to declare CLINICAL SCENARIO 62 y/o male with hx of DM 2, COPD, and HT is admitted with
More informationSteroid Hyperglycemia Chris Lewis, ARNP, BC-ADM, CDE
Steroid Hyperglycemia Chris Lewis, ARNP, BC-ADM, CDE Objectives Explain the pathophysiology of steroid induced hyperglycemia Understand different glucocorticoid duration of action and how that may affect
More informationLessons Learned: Interdisciplinary collaboration to reduce hypoglycemic events
Lessons Learned: Interdisciplinary collaboration to reduce hypoglycemic events Ryan ull, Pharm.., BCPS ssistant Professor of Pharmacy Practice Creighton niversity School of Pharmacy legent Health Lakeside
More informationRoot causes of intraoperative hypoglycemia: a case series.
Thomas Jefferson University Jefferson Digital Commons Department of Anesthesiology Faculty Papers Department of Anesthesiology 12-1-2012 Root causes of intraoperative hypoglycemia: a case series. Eric
More informationINSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE
INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE OBJECTIVES DESCRIBE INSULIN, INCLUDING WHERE IT COMES FROM AND WHAT IT DOES STATE THAT
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationINTENSIVE INSULIN THERAPY: A Long History of Conflicting Data.
INTENSIVE INSULIN THERAPY: A Long History of Conflicting Data. Candice Preslaski, PharmD BCPS Clinical Pharmacist Specialist SICU Denver Health Medical Center December 2014 OBJECTIVES Review the risk factors
More informationInvestigators, study sites Multicenter, 35 US sites. Coordinating Investigator: Richard Bergenstal, MD
STUDY SYNOPSIS Study number Title HMR1964A/3502 Apidra (insulin glulisine) administered in a fixed-bolus regimen vs. variable-bolus regimen based on carbohydrate counting in adult subjects with type 2
More informationHyperglycemia in ACS. Dr. Imhemed Eljazwi
Hyperglycemia in ACS 2012-5-8 Dr. Imhemed Eljazwi Percentage of Population (n = 1181) Prevalence of Hyperglycemia in 181 Cardiac Patients Without Known Diabetes 100% 75% 50% 66% of AMI patients have
More informationFluid Balance in an Enhanced Recovery Pathway. Edwin Itenberg, DO, FACS, FASCRS St. Joseph Mercy Oakland MSQC/ASPIRE Meeting April 28, 2017
Fluid Balance in an Enhanced Recovery Pathway Edwin Itenberg, DO, FACS, FASCRS St. Joseph Mercy Oakland MSQC/ASPIRE Meeting April 28, 2017 No Disclosures 2 Introduction The optimal intravenous fluid regimen
More informationThe Coalition for Quality in Geriatric Surgery. Ronnie A. Rosenthal, MS, MD, FACS
The Coalition for Quality in Geriatric Surgery Ronnie A. Rosenthal, MS, MD, FACS Disclosures I receive an honorarium from the Coalition for Quality in Geriatric Surgery grant The Aging U.S. Population
More informationImproving Glycemic Control in the Critical Care
Improving Glycemic Control in the Critical Care Setting /Hospitalists Outline Review current guidelines Review current glycemic targets DKA Treatment Building a perfect glycemic control protocol Transition
More informationPerioperative glycemic control. Ayman A Radi MD*, Nagwa M Doha MD*, Wafiya R Mahdy and Mohamed Hamdin Mandor M.B.B.Ch**
Perioperative glycemic control Ayman A Radi MD*, Nagwa M Doha MD*, Wafiya R Mahdy and Mohamed Hamdin Mandor M.B.B.Ch** * Department of Anesthesia and Intensive Care Medicine, Faculty of Medicine, Menofyia
More informationDiabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE
Diabetes: Definition Pathophysiology Treatment Goals By Scott Magee, MD, FACE Disclosures No disclosures to report Definition of Diabetes Mellitus Diabetes Mellitus comprises a group of disorders characterized
More informationNutrition in the perioperative period Topic 17
Nutrition in the perioperative period Topic 17 Module 17.1 Metabolic Responses to Surgical Stress Olle Ljungqvist Learning Objectives Understand how the body reacts to injury and surgery; Have knowledge
More informationHypoglycemia Reduction STARTER PACK WEBINAR #1
Hypoglycemia Reduction STARTER PACK WEBINAR #1 Why is it important to reduce hypoglycemia? Why Hypoglycemia Reduction? Key Statistics Overall 29% reduction in ADEs since 2010 Hypoglycemia still occurs
More informationUniversity of Groningen. Acute kidney injury after cardiac surgery Loef, Berthus Gerard
University of Groningen Acute kidney injury after cardiac surgery Loef, Berthus Gerard IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it.
More informationIntensive Insulin in the Intensive Care Unit
TABLE OF CONTENTS Introduction to Intensive Insulin in Adult Critical Care Patients - UIMCC Guideline for Insulin Infusion in Adult ICU Patients - P&T Committee Formulary Action Intensive Insulin in the
More informationHyperglycemia is common among medical and surgical. Clinical Guideline
Clinical Guideline Annals of Internal Medicine Intensive Insulin Therapy in Hospitalized Patients: A Systematic Review Devan Kansagara, MD, MCR; Rongwei Fu, PhD; Michele Freeman, MPH; Fawn Wolf, MD; and
More informationCorporate Medical Policy
Corporate Medical Policy Continuous Monitoring of Glucose in the Interstitial Fluid File Name: Origination: Last CAP Review: Next CAP Review: Last Review: continuous_monitoring_of_glucose_in_the_interstitial_fluid
More informationA toolbox to improve algorithms for insulin-dosing decision support
548 A toolbox to improve algorithms for insulin-dosing decision support K. Donsa 1 ; P. Beck 1 ; J. Plank 2 ; L. Schaupp 2 ; J. K. Mader 2 ; T. Truskaller 1 ; B. Tschapeller 1 ; B. Höll 1 ; S. Spat 1 ;
More informationIt s Just a Waived Glucose, Isn t It?
It s Just a Waived Glucose, Isn t It? What Is the Next Step? Becky Damiani, MT (ASCP), Senior Inspection Specialist Laboratory Accreditation Program Objectives Understand the CLIA requirements surrounding
More informationManagement of adults with diabetes undergoing surgery and elective procedures: Improving standards
Management of adults with diabetes undergoing surgery and elective procedures: Improving standards Revised September 2015 Changes in the second edition of the peri-operative document Preoperative pathway
More informationMANAGEMENT OF HYPERGLYCEMIA IN CRITICALLY ILL SURGICAL (NON-CARDIAC) PATIENTS
DISCLAIMER: These guidelines were prepared by the Department of Surgical Education, Orlando Regional Medical Center. They are intended to serve as a general statement regarding appropriate patient care
More informationJMSCR Vol 05 Issue 07 Page July 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i7.76 A Comparative Study of the Effect of Spinal
More information4/23/2015. Linda Steinkrauss, MSN, PNP. No conflicts of interest
Linda Steinkrauss, MSN, PNP No conflicts of interest 1 5 year old African-American female presented to our Endocrinology Clinic with hypoglycemia Abnormal chromosomes Duplication of 11q13.5-11p14.1 affecting
More informationChapter 37: Exercise Prescription in Patients with Diabetes
Chapter 37: Exercise Prescription in Patients with Diabetes American College of Sports Medicine. (2010). ACSM's resource manual for guidelines for exercise testing and prescription (6th ed.). New York:
More informationBasic pathophysiology of recovery: the role of endocrine metabolic response. Franco Carli McGill University Montreal, Canada
Basic pathophysiology of recovery: the role of endocrine metabolic response Franco Carli McGill University Montreal, Canada ASER, Washington, 2016 postoperative recovery, 1950 Loss of body weight, less
More informationWhat Should Be the Therapeutic Glycemic Target in Intensive Care Units?
What Should Be the Therapeutic Glycemic Target in Intensive Care Units? Irl B. Hirsch, M.D. Professor of Medicine University of Washington School of Medicine Disclosures Research/Grants: Sanofi, Halozyme
More information